|
English
|
正體中文
|
简体中文
|
总笔数 :2823020
|
|
造访人次 :
30201597
在线人数 :
958
教育部委托研究计画 计画执行:国立台湾大学图书馆
|
|
|
"wu tai hsien"的相关文件
显示项目 1-5 / 5 (共1页) 1 每页显示[10|25|50]项目
臺大學術典藏 |
2018-09-10T09:24:01Z |
Pyridoxamine ameliorates the effects of advanced glycation end products on subtotal nephrectomy induced chronic renal failure rats
|
Chuang, Yao-Chen;Wu, Ming-Shiou;Wu, Tai-Hsien;Su, Yi-Kai;Lee, Yi-Min; Chuang, Y.-C. and Wu, M.-S. and Wu, T.-H. and Su, Y.-K. and Lee, Y.-M.; 吳明修; Chuang, Yao-Chen; MING-SHIOU WU; Wu, Ming-Shiou; Wu, Tai-Hsien; Su, Yi-Kai; Lee, Yi-Min |
淡江大學 |
2015-01-01 |
Predicting Cancer Risks from Dental Computed Tomography
|
Wu, Tai-Hsien;Lin, Wei-Chan;Chen, Wun-Ke;(張玉坤), Yue-Cune Chang;Hwang, Jeng-Jong |
淡江大學 |
2015-01 |
Predicting Cancer Risks from Dental Computed Tomography
|
Wu, Tai-Hsien; Lin, Wei-Chan; Chen, Wun-Ke; Chang, Yue-Cune; Hwang, Jeng-Jong |
國立臺灣大學 |
2012 |
Pyridoxamine ameliorates the effects of advanced glycation end products on subtotal nephrectomy induced chronic renal failure rats
|
Chuang, Yao-Chen; Wu, Ming-Shiou; Wu, Tai-Hsien; Su, Yi-Kai; Lee, Yi-Min; 吳明修 |
中國醫藥大學 |
1991 |
以AP-1為標的開發抗肝細胞轉形藥物; Development of the Anti-hepatocellular Transformation Compound by Using Activator Protein 1 as the Target
|
吳泰賢; Wu Tai Hsien |
显示项目 1-5 / 5 (共1页) 1 每页显示[10|25|50]项目
|